Symptoms, transmission, prevention and treatment of toxoplasmosis.
D000328:Adult; D000818:Animals; D002371:Cat Diseases; D002415:Cats; D002648:Child; D004285:Dogs; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008198:Lymph Nodes; D008206:Lymphatic Diseases / Q000209:etiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma / Q000254:growth & development; D014123:Toxoplasmosis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D014124:Toxoplasmosis, Animal; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis; D015047:Zoonoses / Q000517:prevention & control
D013411:Sulfadiazine; D011739:Pyrimethamine